Mueller AM, Langwieser N, Bradaric C, Haller B, Fusaro M, Ott I, Von Beckerath N, Kastrati A, Laugwitz KL, Ibrahim T (2018)
Publication Type: Journal article
Publication year: 2018
Book Volume: 69
Pages Range: 308-315
Journal Issue: 4
We evaluated safety and long-term outcome of endovascular therapy for steno-occlusive iliac artery disease. All endovascular procedures of iliac artery lesions performed at our institution between 2001 and 2014 (n = 676) were retrospectively analyzed. The overall technical success rate was 99% and yielded 100% for stenoses (n = 596) and 95% for chronic total occlusions (n = 80). Lesion complexity defined by the Trans-Atlantic Inter-Society Consensus (TASC) II classification had no impact on success rates (TASC A + B vs C + D; 99.5% vs 98.6%, P =.359). During a median follow-up of 11 months, the overall rate of restenosis was 9.4%. After 1 and 3 years, the primary patency rates were 94% and 86% and the secondary patency rate was 100%, respectively. The TASC II classification had no impact on long-term patency rates (TASC A + B vs C + D; 86% vs 81%). In a multivariable analysis, stent diameter remained the only significant predictor for restenosis (hazard ratio: 0.58; 95% confidence interval: 0.41%-0.81%; P =.002). In this single-center retrospective study, endovascular therapy for steno-occlusive iliac artery disease was associated with high technical and clinical success rates as well as an excellent long-term patency rate irrespective of lesion complexity.
APA:
Mueller, A.M., Langwieser, N., Bradaric, C., Haller, B., Fusaro, M., Ott, I.,... Ibrahim, T. (2018). Endovascular Treatment for Steno-Occlusive Iliac Artery Disease: Safety and Long-Term Outcome. Angiology, 69(4), 308-315. https://doi.org/10.1177/0003319717720052
MLA:
Mueller, Arne M., et al. "Endovascular Treatment for Steno-Occlusive Iliac Artery Disease: Safety and Long-Term Outcome." Angiology 69.4 (2018): 308-315.
BibTeX: Download